Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zarzio in Severe Chronic Neutropenia
NCT01859637Phase 4Terminated
- Sponsor
- Sandoz
- Start
- Jul 2011
- Primary completion
- Mar 2014
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 4 trial of filgrastim in severe chronic neutropenia (SCN), sponsored by Sandoz. Started Jul 2011; status: terminated.
02
Drugs
filgrastim
03
Conditions
severe chronic neutropenia (SCN)
Beyond the preview
Go deeper on NCT01859637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01859637.